Proteomics Intl Labs Ltd has released a press release.
$4.5m placement to launch Promarker diagnostics
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Trading Halt
- Pause in Trading
- Australian patent granted for OxiDx oxidative stress test
- Response to ASX Aware Query
- PromarkerD predictive test for DKD launched in Australia
Later from Proteomics International Laboratories
- Share Purchase Plan Offer Booklet
- Chinese patent granted for OxiDx technology
- PromarkerEndo latest results presented at world congress
- $12 million capital raise completed with oversubscribed SPP
- A landmark in non-invasive Esophageal Cancer diagnosis
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories